{
  "name": "Swedish Orphan Biovitrum AB",
  "slug": "swedish-orphan-biovitrum-ab",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-05T23:38:11Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-05: stängning 440.80, volym 306646",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/swedish-orphan-biovitrum-ab/reports",
    "count": 17,
    "nasdaq_count": 17,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q2",
        "period_label": "2026 Q2",
        "date": "2026-07-16",
        "title": "Kvartalsrapport Q2 2026",
        "original_title": "Delårsrapport för andra kvartalet 2026: Betydande tillväxt med viktiga framsteg i pipeline",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b365e03256abb7257729b91f1fdb739b5&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
            "title": "Kvartalsrapport Q2 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a2d4ce634319b47e67508fcb6cb34241c",
            "date": "2026-07-16",
            "period": "2026-q2",
            "form_type": "interim-report",
            "report_key": "2026:q2",
            "filename": "07159325.pdf",
            "text_chars": 95367,
            "sha256": "a34cda4a5b706a0431497a4779e306b88014ff959e91108f7004b7bc5bf7176f",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
                "chars": 95367
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-04-28",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Delårsrapport för första kvartalet 2026: Stark leverans och viktiga framsteg i pipeline",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bed68bf42c6b0537709ebdf78beb3fa2b&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a8a7a6601c2707c4b51e02e890746db2f",
            "date": "2026-04-28",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "04274767.pdf",
            "text_chars": 81834,
            "sha256": "b17b8a3e88ae51823e04f53e569bec75bad8751bc3b6465fb285cb18dccd5eb6",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 81834
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-03-31",
        "title": "Årsredovisning 2025",
        "original_title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2025",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bbee04901d0f6d47c2d106193ba757199&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a803413b852d7619e00ffe60a724e1771",
            "date": "2026-03-31",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "03260875.pdf",
            "text_chars": 803680,
            "sha256": "fd8fcf28461ff21c27a6d013e4c251d1b92a88ace95916316406226328217ab2",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 177160
              },
              {
                "number": 2,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 178827
              },
              {
                "number": 3,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-003.html",
                "chars": 174083
              },
              {
                "number": 4,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-004.html",
                "chars": 179401
              },
              {
                "number": 5,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-005.html",
                "chars": 94201
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-05",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2025: Året avslutas med betydande tillväxt och strategiska framsteg",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=be43ea8f84c7f543211d60ffb0ee38389&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a2dc581a992b369dca4b24f3a09c91ce2",
            "date": "2026-02-05",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "02046223.pdf",
            "text_chars": 87369,
            "sha256": "a2cc733202c349e0f23a0a66ad6511d755bc8758dc925ee45b1992f67c565298",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 87369
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-10-20",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Sobi publicerar delårsrapport för tredje kvartalet 2025: Accelererad tillväxt och momentum i portföljen",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b71dc6f1b63155386dcbeaa46922c9138&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad0ebc4a6d6b69a0d790480924eecfcce",
            "date": "2025-10-20",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "10195737.pdf",
            "text_chars": 95082,
            "sha256": "36fffff42260f19d0513ca423002caaf2a7bd69d24200999387039e4c8e89fb0",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 95082
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-07-16",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "Sobi publicerar delårsrapport för andra kvartalet 2025: Fortsatt starkt momentum i portfölj och pipeline",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b0cf7fdf0365e2db9afdb4c2b3805d450&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/abaad6a191845e90e57292d3057ecd186",
            "date": "2025-07-16",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "07159972.pdf",
            "text_chars": 85283,
            "sha256": "4af6df9a017876eecf7a09b68e407080a211b7644ca383f2d0e87921598bd92a",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 85283
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-04-29",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "Sobi publicerar delårsrapport för första kvartalet 2025: Portföljen fortsätter att leverera",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b2ced551b8b75d310c83a7ba33d19a3cc&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a845fd2722e07b9aaa05e3d2cfbc26000",
            "date": "2025-04-29",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "04283614.pdf",
            "text_chars": 71886,
            "sha256": "a1cfb110b5623431908cb455ccdfc00c62ef13dbaa377bfe543b42a76805f04b",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 71886
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-03-31",
        "title": "Årsredovisning 2024",
        "original_title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2024",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b6295957feca0dfeda661776c554f69ad&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a0959a7d05a6fcf8fe7bdfb639249c3e8",
            "date": "2025-03-31",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "03277258.pdf",
            "text_chars": 712072,
            "sha256": "e58e5e6fcae3dbe82a8cd98cd91edb16a2c34d325a055692239bceaec4aa5447",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 179806
              },
              {
                "number": 2,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 177327
              },
              {
                "number": 3,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-003.html",
                "chars": 176398
              },
              {
                "number": 4,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-004.html",
                "chars": 178535
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-02-05",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2024: Starkt avslut på ett framgångsrikt år",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b908a0f33e1d726c33c427edfe8364e84&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a023e6a80152f1c92f009fd9ee16a0933",
            "date": "2025-02-05",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "02041851.pdf",
            "text_chars": 82419,
            "sha256": "f6caa376e1fd958c217d3fb05b7e9aeaac3999cfadcbba3c24142f35df417f69",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 82419
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-10-24",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "Sobi publicerar delårsrapport för tredje kvartalet 2024: Stark tillväxt och väsentliga framsteg i pipeline",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b38af79e7e83c8ee2438b1d66ea802a36&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a663c36aa30977493cbca55d44f3473e8",
            "date": "2024-10-24",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "10236498.pdf",
            "text_chars": 83194,
            "sha256": "5ba80e24f38d110e6f69c5f05792486b46fc677a43532d649903d6d1dc6212a6",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 83194
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-07-16",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "Sobi publicerar delårsrapport för andra kvartalet 2024: Stark leverans driven av robust utveckling i portföljen",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b3ca6c22d01335bbc3ad7becda29f2f63&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a30f3433f133728239646c72979408bc8",
            "date": "2024-07-16",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "07155900.pdf",
            "text_chars": 79272,
            "sha256": "2beb780fc696e0cdc36ad6c847af8ea887fe5173fc37488471dcb4866a564363",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 79272
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-04-25",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "Sobi publicerar delårsrapport för första kvartalet 2024: Stark försäljning speglar styrkan i portföljen",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bf19a885a6ffb3ee929892e3dd31a5614&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a859af69b59fde0bbeaea3f650018db9f",
            "date": "2024-04-25",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "04247488.pdf",
            "text_chars": 72854,
            "sha256": "93cce24ab1bc25e4919a1340756e72ba8c5e1d74aa66fce087ca8ff1982ac26b",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 72854
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-04-02",
        "title": "Årsredovisning 2023",
        "original_title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2023",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b674ba2f74fae1b353eb07c2629f99b0c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a3a0129a40ccc4e88990e701eed9d58fb",
            "date": "2024-04-02",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "03273911.pdf",
            "text_chars": 610135,
            "sha256": "2e692ad7e8c497878cdca331763d72469c7bd11f6d110bdcf44968032bd28cb4",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 171277
              },
              {
                "number": 2,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 179719
              },
              {
                "number": 3,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-003.html",
                "chars": 175384
              },
              {
                "number": 4,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-004.html",
                "chars": 83749
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-08",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2023: Stark intäktsutveckling och tillväxt in i 2024",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b82a48fcad5e4336da5c54b0ae1dd521d&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/adde0b322dea3c5b52faacfe607f60b9c",
            "date": "2024-02-08",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "02073988.pdf",
            "text_chars": 80677,
            "sha256": "69fd59510737bbc9c3bfa404f2cf4c3af955915b786cbf5564668e7451ad055b",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 80677
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-10-30",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "Sobi publicerar delårsrapport för tredje kvartalet 2023: Stark försäljning och stabil leverans",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b92ac36d21ba1be39d3c190e77f91cad2&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7c69cbef88bfba2017353bab0c4b272f",
            "date": "2023-10-30",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "10284167.pdf",
            "text_chars": 81081,
            "sha256": "dbf191c8acb11841235477fa308d2ff22f5521f309168824aede1b306863c4ae",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 81081
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-07-18",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Sobi publicerar delårsrapport för andra kvartalet 2023: Tillväxt och utökad pipeline",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bcbbe240e554895c93760cb53d1624ffe&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad1ceec26e0bd18055c21d64818ce3a6b",
            "date": "2023-07-18",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "07174924.pdf",
            "text_chars": 84136,
            "sha256": "7234f04db1009d9a9039d6b0c0fc4820db51d777a11f09d99f2df0904ffde798",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 84136
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-04-27",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "Sobi publicerar delårsrapport för första kvartalet 2023: Fortsatt stabil utveckling",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=baecfed01956ab788b0df2c9c5dd1fc8f&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa660dc1176676aee312b120c11a1d606",
            "date": "2023-04-27",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "04267261.pdf",
            "text_chars": 69614,
            "sha256": "f3cc4e5143ede980a0eab03e39b37a19d68a2704e3634614ab759118d70f1bda",
            "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 69614
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 17,
  "nasdaq_report_count": 17,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "Swedish Orphan Biovitrum AB",
    "identity": {
      "issuer": "Swedish Orphan Biovitrum AB (publ)",
      "lei": "549300124Y3MQI87PT35",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 142,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Swedish Orphan Biovitrum AB",
      "query": "Swedish Orphan Biovitrum AB (publ)",
      "candidate_count": 346
    },
    "period": {
      "from": "2024-08-04",
      "to": "2026-08-04",
      "years": 2
    },
    "generated_at": "2026-08-04T05:43:38Z",
    "insider": {
      "transactions": 141,
      "all_export_rows": 141,
      "acquisitions": 56,
      "disposals": 60,
      "other": 25,
      "acquisition_value_sek": 551049507.91,
      "disposal_value_sek": 997509767.75,
      "characters": {
        "Avyttring": 60,
        "Förvärv": 56,
        "Tilldelning": 25
      }
    },
    "short_selling": {
      "aggregate_percent": 1.21,
      "current_public_positions": 0,
      "historical_changes": 19,
      "current_position_sum_over_0_5": 0
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "sobi",
      "instrument_id": "TX211528",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/sobi?id=TX211528"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "Swedish Orphan Biovitrum",
      "expected_name": "Swedish Orphan Biovitrum AB",
      "match_score": 100.0,
      "slug": "swedish-orphan-biovitrum",
      "url": "https://mfn.se/all/a/swedish-orphan-biovitrum",
      "metadata": {
        "country": "Sverige",
        "list": "Large Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Läkemedel & Handel",
        "website": "https://mb.cision.com/Main/14266/4379300/4207474.pdf"
      },
      "ticker_candidates": [],
      "attempts": [
        {
          "slug": "swedish-orphan-biovitrum-ab",
          "url": "https://mfn.se/all/a/swedish-orphan-biovitrum-ab",
          "status": "identity_mismatch",
          "title": "",
          "score": 0.0
        }
      ]
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX211528",
      "asset_class": "SHARES",
      "isin": "SE0000872095",
      "symbol": "SOBI",
      "company": "Swedish Orphan Biovitrum",
      "market": null,
      "last_sale_price": "SEK 440.80",
      "time_as_of": "2026-08-05"
    },
    "finansinspektionen": {
      "issuer": "Swedish Orphan Biovitrum AB (publ)",
      "lei": "549300124Y3MQI87PT35",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 142,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Swedish Orphan Biovitrum AB",
      "query": "Swedish Orphan Biovitrum AB (publ)",
      "candidate_count": 346
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
      "title": "Kvartalsrapport Q2 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a2d4ce634319b47e67508fcb6cb34241c",
      "date": "2026-07-16",
      "period": "2026-q2",
      "form_type": "interim-report",
      "report_key": "2026:q2",
      "filename": "07159325.pdf",
      "text_chars": 95367,
      "sha256": "a34cda4a5b706a0431497a4779e306b88014ff959e91108f7004b7bc5bf7176f",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
          "chars": 95367
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a8a7a6601c2707c4b51e02e890746db2f",
      "date": "2026-04-28",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "04274767.pdf",
      "text_chars": 81834,
      "sha256": "b17b8a3e88ae51823e04f53e569bec75bad8751bc3b6465fb285cb18dccd5eb6",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 81834
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a803413b852d7619e00ffe60a724e1771",
      "date": "2026-03-31",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "03260875.pdf",
      "text_chars": 803680,
      "sha256": "fd8fcf28461ff21c27a6d013e4c251d1b92a88ace95916316406226328217ab2",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 177160
        },
        {
          "number": 2,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 178827
        },
        {
          "number": 3,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-003.html",
          "chars": 174083
        },
        {
          "number": 4,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-004.html",
          "chars": 179401
        },
        {
          "number": 5,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-005.html",
          "chars": 94201
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a2dc581a992b369dca4b24f3a09c91ce2",
      "date": "2026-02-05",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "02046223.pdf",
      "text_chars": 87369,
      "sha256": "a2cc733202c349e0f23a0a66ad6511d755bc8758dc925ee45b1992f67c565298",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 87369
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad0ebc4a6d6b69a0d790480924eecfcce",
      "date": "2025-10-20",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "10195737.pdf",
      "text_chars": 95082,
      "sha256": "36fffff42260f19d0513ca423002caaf2a7bd69d24200999387039e4c8e89fb0",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 95082
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/abaad6a191845e90e57292d3057ecd186",
      "date": "2025-07-16",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "07159972.pdf",
      "text_chars": 85283,
      "sha256": "4af6df9a017876eecf7a09b68e407080a211b7644ca383f2d0e87921598bd92a",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 85283
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a845fd2722e07b9aaa05e3d2cfbc26000",
      "date": "2025-04-29",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "04283614.pdf",
      "text_chars": 71886,
      "sha256": "a1cfb110b5623431908cb455ccdfc00c62ef13dbaa377bfe543b42a76805f04b",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 71886
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a0959a7d05a6fcf8fe7bdfb639249c3e8",
      "date": "2025-03-31",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "03277258.pdf",
      "text_chars": 712072,
      "sha256": "e58e5e6fcae3dbe82a8cd98cd91edb16a2c34d325a055692239bceaec4aa5447",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 179806
        },
        {
          "number": 2,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 177327
        },
        {
          "number": 3,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-003.html",
          "chars": 176398
        },
        {
          "number": 4,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-004.html",
          "chars": 178535
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a023e6a80152f1c92f009fd9ee16a0933",
      "date": "2025-02-05",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "02041851.pdf",
      "text_chars": 82419,
      "sha256": "f6caa376e1fd958c217d3fb05b7e9aeaac3999cfadcbba3c24142f35df417f69",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 82419
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a663c36aa30977493cbca55d44f3473e8",
      "date": "2024-10-24",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "10236498.pdf",
      "text_chars": 83194,
      "sha256": "5ba80e24f38d110e6f69c5f05792486b46fc677a43532d649903d6d1dc6212a6",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 83194
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a30f3433f133728239646c72979408bc8",
      "date": "2024-07-16",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "07155900.pdf",
      "text_chars": 79272,
      "sha256": "2beb780fc696e0cdc36ad6c847af8ea887fe5173fc37488471dcb4866a564363",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 79272
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a859af69b59fde0bbeaea3f650018db9f",
      "date": "2024-04-25",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "04247488.pdf",
      "text_chars": 72854,
      "sha256": "93cce24ab1bc25e4919a1340756e72ba8c5e1d74aa66fce087ca8ff1982ac26b",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 72854
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a3a0129a40ccc4e88990e701eed9d58fb",
      "date": "2024-04-02",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "03273911.pdf",
      "text_chars": 610135,
      "sha256": "2e692ad7e8c497878cdca331763d72469c7bd11f6d110bdcf44968032bd28cb4",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 171277
        },
        {
          "number": 2,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 179719
        },
        {
          "number": 3,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-003.html",
          "chars": 175384
        },
        {
          "number": 4,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-004.html",
          "chars": 83749
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/adde0b322dea3c5b52faacfe607f60b9c",
      "date": "2024-02-08",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "02073988.pdf",
      "text_chars": 80677,
      "sha256": "69fd59510737bbc9c3bfa404f2cf4c3af955915b786cbf5564668e7451ad055b",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 80677
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7c69cbef88bfba2017353bab0c4b272f",
      "date": "2023-10-30",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "10284167.pdf",
      "text_chars": 81081,
      "sha256": "dbf191c8acb11841235477fa308d2ff22f5521f309168824aede1b306863c4ae",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 81081
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad1ceec26e0bd18055c21d64818ce3a6b",
      "date": "2023-07-18",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "07174924.pdf",
      "text_chars": 84136,
      "sha256": "7234f04db1009d9a9039d6b0c0fc4820db51d777a11f09d99f2df0904ffde798",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 84136
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa660dc1176676aee312b120c11a1d606",
      "date": "2023-04-27",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "04267261.pdf",
      "text_chars": 69614,
      "sha256": "f3cc4e5143ede980a0eab03e39b37a19d68a2704e3634614ab759118d70f1bda",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 69614
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/swedish-orphan-biovitrum",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 15879,
      "sha256": "db955449898c86fa5d2ec49d216074dc77685807a667eb506454dc23daf2b5f5",
      "url": "/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 15879
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/swedish-orphan-biovitrum-ab/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/swedish-orphan-biovitrum-ab/market/history.json",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/swedish-orphan-biovitrum-ab/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/swedish-orphan-biovitrum-ab/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/market/instrument.json"
    },
    {
      "label": "SEC sammanfattning JSON",
      "url": "/company/swedish-orphan-biovitrum-ab/market/sec-summary.json",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/market/sec-summary.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/swedish-orphan-biovitrum-ab/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/swedish-orphan-biovitrum-ab/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": true,
    "status": "retrieved",
    "captured_at": "2026-08-02T17:54:36Z",
    "view_count": 4,
    "url": "/company/swedish-orphan-biovitrum-ab/morningstar",
    "path": "D:\\Web\\aktieanalys\\public\\company\\.swedish-orphan-biovitrum-ab.tmp\\morningstar",
    "files": [
      "index.html",
      "summary.txt",
      "screenshot.png"
    ]
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/swedish-orphan-biovitrum-ab/finansinspektionen",
    "transaction_count": 141,
    "aggregate_short_percent": 1.21,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/swedish-orphan-biovitrum-ab/llms.txt",
  "json_url": "/company/swedish-orphan-biovitrum-ab/company.json",
  "document_index_url": "/company/swedish-orphan-biovitrum-ab/documents.json",
  "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab"
}